Literature DB >> 9494106

Molecular cloning of membrane cofactor protein (MCP; CD46) on B95a cell, an Epstein-Barr virus-transformed marmoset B cell line: B95a-MCP is susceptible to infection by the CAM, but not the Nagahata strain of the measles virus.

Y Murakami1, T Seya, M Kurita, A Fukui, S Ueda, S Nagasawa.   

Abstract

Measles virus (MV) infects not only human beings but also some simian species. The MV receptor on Vero cells (a cell line established from African Green monkey kidney cells) and human cells has been shown to be the membrane cofactor protein MCP/CD46, which is an inhibitor of autologous complement (C) activation. B95a, an Epstein-Barr virus (EBV)-transformed marmoset B cell line, is a simian cell line used for MV selection and is much more susceptible to MV than Vero cells. In the present study, we isolated cDNAs encoding MCP homologues from B95a cDNA library and assessed whether B95a-MCP is responsible for the high susceptibility of B95a to MV. The deduced amino acid sequence of the cDNA of B95a-MCP was 76% identical to that of human-MCP, and the recombinant B95a-MCP exerts C inhibitor activity. Although CAM, a vaccine strain of MV, infected Chinese hamster ovary (CHO) cells expressing B95a-MCP, Nagahata strain, a wild type of MV, failed to infect the CHO transfectants, suggesting that additional membrane molecules of B95a are responsible for the high susceptibility of B95a to the Nagahata strain.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9494106      PMCID: PMC1219282          DOI: 10.1042/bj3301351

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  47 in total

1.  Mechanism of action of the C3b inactivator: requirement for a high molecular weight cofactor (C3b-C4bINA cofactor) and production of a new C3b derivative (C3b').

Authors:  S Nagasawa; R M Stroud
Journal:  Immunochemistry       Date:  1977 Nov-Dec

2.  Characterization of the human trophoblast-leukocyte antigenic molecules defined by a monoclonal antibody.

Authors:  P L Stern; N Beresford; S Thompson; P M Johnson; P D Webb; N Hole
Journal:  J Immunol       Date:  1986-09-01       Impact factor: 5.422

3.  Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedure and some applications.

Authors:  H Towbin; T Staehelin; J Gordon
Journal:  Proc Natl Acad Sci U S A       Date:  1979-09       Impact factor: 11.205

4.  Development of extremely attenuated live measles virus vaccine (CAM-EX).

Authors:  S Ueda; M Takahashi; T Kurimura; Y Minekawa; N Suzuki
Journal:  Biken J       Date:  1972-09

5.  Cleavage of structural proteins during the assembly of the head of bacteriophage T4.

Authors:  U K Laemmli
Journal:  Nature       Date:  1970-08-15       Impact factor: 49.962

6.  3' non-coding region sequences in eukaryotic messenger RNA.

Authors:  N J Proudfoot; G G Brownlee
Journal:  Nature       Date:  1976-09-16       Impact factor: 49.962

7.  Hu Ly-m5: a unique antigen physically associated with HLA molecules.

Authors:  R L Sparrow; I F McKenzie
Journal:  Hum Immunol       Date:  1983-05       Impact factor: 2.850

8.  Studies on further attenuated live measles vaccine. I. Adaptation of measles virus to the chorioallantoic membrane of chick embryo and clinical tests on the strain.

Authors:  S Ueda; M Takahashi; Y Minekawa; T Ogino; N Suzuki
Journal:  Biken J       Date:  1970-06

9.  Cleavage of C4b by C3b inactivator: production of a nicked form of C4b, C4b', as an intermediate cleavage product of C4b by C3b inactivator.

Authors:  S Nagasawa; C Ichihara; R M Stroud
Journal:  J Immunol       Date:  1980-08       Impact factor: 5.422

10.  Purification and characterization of a membrane protein (gp45-70) that is a cofactor for cleavage of C3b and C4b.

Authors:  T Seya; J R Turner; J P Atkinson
Journal:  J Exp Med       Date:  1986-04-01       Impact factor: 14.307

View more
  3 in total

1.  CD150 (SLAM) is a receptor for measles virus but is not involved in viral contact-mediated proliferation inhibition.

Authors:  C Erlenhoefer; W J Wurzer; S Löffler; S Schneider-Schaulies; V ter Meulen; J Schneider-Schaulies
Journal:  J Virol       Date:  2001-05       Impact factor: 5.103

2.  Human herpesvirus 6 variant A but not variant B induces fusion from without in a variety of human cells through a human herpesvirus 6 entry receptor, CD46.

Authors:  Yasuko Mori; Tsukasa Seya; Hong Lan Huang; Pilailuk Akkapaiboon; Panadda Dhepakson; Koichi Yamanishi
Journal:  J Virol       Date:  2002-07       Impact factor: 5.103

3.  Novel marmoset (Callithrix jacchus) model of human Herpesvirus 6A and 6B infections: immunologic, virologic and radiologic characterization.

Authors:  Emily Leibovitch; Jillian E Wohler; Sheila M Cummings Macri; Kelsey Motanic; Erin Harberts; María I Gaitán; Pietro Maggi; Mary Ellis; Susan Westmoreland; Afonso Silva; Daniel S Reich; Steven Jacobson
Journal:  PLoS Pathog       Date:  2013-01-31       Impact factor: 6.823

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.